Cargando…
Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Derivatives
Chitosan and its derivatives can alleviate metabolic syndrome by different regulation mechanisms, phosphorylation of AMPK (AMP-activated kinase) and Akt (also known as protein kinase B), suppression of PPAR-γ (peroxisome proliferator-activated receptor-γ) and SREBP-1c (sterol regulatory element–bind...
Autores principales: | Yan, Chen, Zhang, Cuili, Cao, Xuejiao, Feng, Bin, Li, Xinli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764266/ https://www.ncbi.nlm.nih.gov/pubmed/33322383 http://dx.doi.org/10.3390/molecules25245857 |
Ejemplares similares
-
Chitosan Ameliorates DSS-Induced Ulcerative Colitis Mice by Enhancing Intestinal Barrier Function and Improving Microflora
por: Wang, Jia, et al.
Publicado: (2019) -
Chitosan Oligosaccharide Ameliorates Metabolic Syndrome Induced by Overnutrition via Altering Intestinal Microbiota
por: Wang, Yihua, et al.
Publicado: (2021) -
Thermosensitive hydrogel based on chitosan and its derivatives containing medicated nanoparticles for transcorneal administration of 5-fluorouracil
por: Fabiano, Angela, et al.
Publicado: (2017) -
Neuroprotective Properties of Chitosan and Its Derivatives
por: Pangestuti, Ratih, et al.
Publicado: (2010) -
Antidiabetic Properties of Chitosan and Its Derivatives
por: Tzeng, Huei-Ping, et al.
Publicado: (2022)